tiprankstipranks
Awakn Life Sciences Corp (AWKNF)
:AWKNF
US Market

Awakn Life Sciences (AWKNF) Financial Statements

Compare
10 Followers

Awakn Life Sciences Financial Overview

Awakn Life Sciences's market cap is currently $2.78M. The company's EPS TTM is $-0.045; its P/E ratio is ―; Awakn Life Sciences is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Jan 23Jan 22
Income Statement
Total Revenue
Gross Profit$ 87.37K$ -1.55M$ 236.04K
Operating Income$ -3.93M$ -9.19M$ -10.96M
EBITDA$ -3.65M$ -8.78M$ -15.61M
Net Income$ -5.01M$ -9.14M$ -15.47M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 543.35K$ 4.39M$ 6.88M
Total Debt$ 0.00$ 2.30M$ 1.81M
Net Debt$ -407.30K$ 1.74M$ 185.68K
Total Liabilities$ 2.07M$ 4.44M$ 3.85M
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -2.38M$ -7.46M$ -10.29M
Operating Cash Flow$ -2.38M$ -7.36M$ -8.59M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Awakn Life Sciences Earnings and Revenue History

Awakn Life Sciences Debt to Assets

Awakn Life Sciences Cash Flow

Awakn Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis